The function of the KCNQ4 channel in the auditory setting is crucial to hearing, underpinned by the finding that mutations of the channel result in an autosomal dominant form of nonsyndromic progressive high frequency hearing loss (PHFHL). The precise function of KCNQ4 in the inner ear has not been established. However, recently we demonstrated that there is differential expression among four splice variants of KCNQ4 (KCNQ4_v1-v4) along the tonotopic axis of the cochlea. Alternative splicing specifies the outcome of functional channels by modifying the amino acid (aa) sequences within the Cterminus, at a site designated as the membrane proximal region (MPR). We show that variations within the Cterminus of splice variants produce profound differences in the voltagedependent phenotype and functional expression of channel. KCNQ4_v4 lacks exons 9-11, resulting in deletion of 54 aa residues adjacent to the S6 domain compared to KCNQ4_v1. Consequently, the voltage-dependent activation of KCNQ4_v4 is shifted leftward by ~20 mV, and the number of functional channels is increased several-fold compared with KCNQ4_v1. The properties of KCNQ4_v2&3 fall between KCNQ4_v1 and KCNQ4_v4. Because of variations in the calmodulin binding domains (CaMBD) of the splice variants, the channels are differentially modulated by CaM. Co-expression of these splice variants yielded current magnitudes suggesting that the channels are composed of heterotetramers. Indeed, a dominant negative (DN) mutant of KCNQ4_v1 cripples the currents of the entire KCNQ4 channel family. Furthermore, the DN KCNQ4 mutant stifles the activity of KCNQ2-5, raising the possibility of a global disruption of KCNQ channel activity and the ensuing auditory phenotype. (11) (12) (13) . Among the C-termini of the splice isoforms of KCNQ4 in the cochlea are variations in the putative CaMBDs, raising the possibility that CaM modulation of the variants may be distinct (8). We are interested in the alternative splicing regions of the channel not only because they occur at the MPR of the C-termini, which is essential for channel targeting to the plasma membrane (14), but also because mutations in similar regions of other KCNQ channels (e.g. KCNQ2) have been linked to disease conditions such as benign familial neonatal convulsion (BFNC) and myokymia (15-17). Given their unique biochemical characteristics and differential expression, we predict that splice variants of KCNQ4 in the cochlea may confer diverse functional phenotypes.
KCNQ channels constitute delayedrectifier K + channels found in a wide range of excitable and non excitable cells to control their membrane potentials, and in so doing regulate Ca 2+ influx. In the inner ear, KCNQ channels are critical for auditory function, as mutations of KCNQ1 and KCNQ4 result in deafness and PHFHL, respectively (1) (2) (3) (4) . Within the cochlea, four members of the KCNQ channel family have been identified by RT-PCR techniques (2) , however only the expression of KCNQ1 and KCNQ4 has been demonstrated and studied in detail (2, 3, 5) . The expression of KCNQ1 is restricted mainly to marginal cells of the strial vascularis, and mutations of the channel abolish the endocochlear potential (5) (6) (7) .
In contrast, KCNQ4 has been identified chiefly in outer and inner hair cells (OHC & IHC) and spiral ganglion neurons (4, (8) (9) (10) . We have previously shown that there is differential expression among the four splice variants of KCNQ4 (KCNQ4_v1-4) along the tonotopic axis of the cochlea (8) . The location-dependent variability in KCNQ4 expression suggests that KCNQ4 channels in the cochlear duct serve specialized physiological functions.
A straightforward but accurate model of KCNQ and other K + channel physiology in the inner ear maintains that the channels serve to regulate membrane potential in order to modulate the level of intracellular Ca 2+ (Ca 2+ i ), which serves as a ubiquitous second messenger. The KCNQ4 current, I K,n , moderates the resting membrane potential of IHCs and consequently controls the [Ca 2+ i ] (4). Thus, it would not be surprising to discover that KCNQ4 is under feedback modulation by the resultant Ca 2+ fluxes that they ultimately regulate. CaM binds to the C-termini of KCNQ channels, possibly as a constitutive auxiliary subunit, and mediates a Ca 2+ -dependent inhibition of the neuronal M-type K + current that constitute KCNQ currents (11) (12) (13) . Among the C-termini of the splice isoforms of KCNQ4 in the cochlea are variations in the putative CaMBDs, raising the possibility that CaM modulation of the variants may be distinct (8) . We are interested in the alternative splicing regions of the channel not only because they occur at the MPR of the C-termini, which is essential for channel targeting to the plasma membrane (14) , but also because mutations in similar regions of other KCNQ channels (e.g. KCNQ2) have been linked to disease conditions such as benign familial neonatal convulsion (BFNC) and myokymia (15) (16) (17) . Given their unique biochemical characteristics and differential expression, we predict that splice variants of KCNQ4 in the cochlea may confer diverse functional phenotypes.
Here, we show that homomeric KCNQ4_v1-4 exhibit distinct voltagedependent properties and membrane expression profiles. Meanwhile, the splice variants form heterotetramers with each other as well as with other KCNQ channels, such that a DN mutant of one channel isoform cripples the entire series of KCNQ2-5 currents. Finally, consistent with variation in the CaMBDs, the channels are differentially modulated by CaM. The functional diversity and the differential tonotopic expression of the KCNQ4 splice variants may underlie the etiology of PHFHL associated with mutations of the channel.
Experimental Procedures Molecular cloning of Kcnq4 channels
Kcnq4_v1 was amplified from a mouse cochlear total RNA using the Advantage-Taq cDNA and Advantage-GC polymerase mixes (BD Bioscience, Palo Alto, CA). Multiple primer sets were used to produce three overlapping fragments. The first fragment was obtained using primer pair 5'-agagagttggagtcggaagagc-3' and 5'-tggagcaggcagtggtaagagc-3', which contained the predicted transcription start site and the entire exon1.
An internal cDNA fragment was prepared using an upstream primer in exon1 (5'-agaactgggtctacaacgtgctgg-3') and a downstream primer in the last exon (exon 14) (5'-gccagggagcgagttcaagtaag-3'). The 3' fragment containing the polyadenylation signal was amplified using a 3' RACE RT-PCR protocol (BD Biosciences, Palo Alto, CA) and an exon14 sense primer (5'-ctgggcactgtgcaagtgccgc-3').
Sequence appropriate clones were selected and cloned into HindIII and XbaI sites of a pCRII-TOPO vector. The resulting full-length mouse Kcnq4_v1 cDNA was sequence verified to insure fidelity of the sequence. Kcnq4_v4 was identified from the RIKEN inner ear subtracted cDNA library (clone F930013D18), but it lacked the very 5' end of exon1 including the predicted ATG start site. A 5' SacI / HindIII fragment from the Kcnq4_v1 was excised and inserted into Kcnq4_v4 to replace the truncated 5' cDNA fragment.
Constructs for heterologous expression in CHO cells
Both Kcnq4_v1 and Kcnq4_v4 channels were sub-cloned into a mammalian cell expression vector pEGFP-N3 (BD Bioscience, Clontech, mountainview, CA). The Kcnq4_v1 clone was first digested with XbaI and blunted with T4 polymerase, and then digested with HindIII. The DNA fragment containing full-length Kcnq4_v1 was cloned into a pEGFP-N3 vector digested with SmaI and HindIII. Similarly, the Kcnq4_v4 was digested with SfiI, blunted-ended and then digested with SacI. The obtained full-length Kcnq4_v4 cDNA fragment was then ligated into SmalI /SacI of pEGFP-N3 vector. The construction of the Kcnq4_v2 and Kcnq4_v3 for the heterologous expression was generated by RT-PCR using the forward Kcnq4-fl-519 (5'-gattgtggtctttggcttggag-3') and the reverse Kcnq4-fl-2166 (5'-ccagggagcgagttcaagtaag-3') primer set with the total RNA obtained from CD1 mouse organ of Corti. The PCR products were subcloned into pCR-II TOPO; the BclI and BsmBI fragments of the cloned Kcnq4_v2 and Kcnq4_v3 were used to replace the BclI/BsmBI fragment of Kcnq4_v1 fragment of pEGFP-N3-Kcnq4_v1. The subsequent pEGFP-N3-Kcnq4_v2 and pEGFP-N3-Kcnq4_v3 clones were verified by sequence analyses. In all of these constructs, EGFP at down-stream of MCS is not expressed since the full-length cDNAs of KCNQ4 variants were used.
Plasmids and series resistance compensation (>90%), and filtered at 2 kHz using an 8-pole Bessel filter, and sampled at 5 kHz. Whole cell K + current amplitude at varying test potentials was measured at the peak and steady-state levels using a peak and steady-state detection routine; the current was divided by the cell capacitance (pF) to generate the current density-voltage relationship.
Nonstationary fluctuation analysis was used to estimate the number (N) of functional channels in the membrane. For a homogeneous population of channels gating independently, the mean macroscopic current (I) is defined as follows: I = N · i · p o . The macroscopic variance (σ 2   is defined as follows: 
RESULTS
Previously, the KCNQ4 channel had been cloned from the human brain and identified in the inner ear (2). Using RT-PCR strategies, we have recently identified and cloned four Kcnq4 splice variants (v) directly from the mouse cochlea (8) . Sequence analysis has revealed that these splice variants were derived from the different utilization of exons 9, 10 and 11 of Kcnq4 gene (Fig. 1A) . Whereas KCNQ4_v1 includes exons 9-11, KCNQ4_v4 excludes the three exons ( Fig. 1A & B) . Analysis of the aa sequences of different KCNQ4 channels revealed that these splice variants are identical except for the C-termini ( Fig.  1C & D) . The C termini of KCNQ channels bears the functional domains for CaM binding (11) (12) (13) , endoplasmic reticulum (ER) retention (22), axon and synapsespecific targeting (14) , as well as protein kinase A (PKA) phosphorylation (23). Thus, we suspect that KCNQ4 splice variants with different C-termini may confer distinct functional phenotypes.
In Figure 2 we illustrate the phenotypic features of KCNQ4_v1 expressed in CHO cells. The current rectifies outwardly, showing stunted growth at hyperpolarized step potentials in contrast to depolarized step potentials from a holding potential of -70 mV ( Fig. 2A) .
The activation voltage of the expressed KCNQ4_v1 was ~-50 mV as shown in the current density-voltage (I-V) relation in figure 2B . From tail current traces, the reversal potential (E rev ) of the current was estimated ( Fig. 2C ) and used to calculate the conductance of the channel at a given step potential. Consistent with a K + -selective channel, the E rev was -85 + 3 mV (n = 9) compared to the expected E rev of -89 mV. The voltage-dependent activation of wholecell current was fit with a Boltzmann function and a half-activation, V 1/2 , of -0.2 + 3.2 mV and a slope factor, k, of 15.2 + 1.8 mV (n = 18) were determined for the KCNQ4_v1 channels. To confirm that the current was indeed derived from KCNQ4 channels, we determined the sensitivity of the current to linopirdine and bepridil, which are known blockers of KCNQ4 currents (24). The current was blocked by both drugs. Shown in figure 2E is the time course blockade by the drugs. The doseresponse curve revealed a linopridine concentration of ~ 11 μM for half-inhibition of current (Fig. 2F) .
To determine the functional significance of C-terminal alterations in KCNQ4_v1-4 variants, CHO cells were transfected with the individual splice variants under similar conditions. Transfection of the four splice variants led to the expression of well-resolved K + currents carried by recombinant KCNQ4 channels. After a 24-hr transfection of equal amounts of cDNA (1μg) for KCNQ4_v1-4, there were striking differences in the relative magnitudes of the whole-cell K + current that ensued from each of the splice variants (Fig.  3A) . Figure 3B compares the I-V relation of the four splice variants, showing significant differences between KCNQ4_v1 and KCNQ4_v2-4 currents. The mean current densities (I (pA/pF)) at 60 mV step potential were; 9.9 + 2.9; 25.3 + 2.6; 31.8 + 2.1; and 111.4 + 9.4 for KCNQ4_v1-4 (n = 18; p < 0.05), respectively. The voltage-dependent activation curves were also dissimilar between the four splice variants (Fig. 3C) . The largest effect was ~20 mV-negative voltage shift in the V 1/2 of the steady-state activation curve for KCNQ4_v4 compared with the V 1/2 of KCNQ4_v1. Descriptive statistics of the V 1/2 (mV) of splice variants were: -0.2 + 4.1; -17.1 + 4.4; -18.6 + 3.6; and -21.5 + 1.0 for KCNQ4_v1-4 (n = 14; p < 0.05), respectively. To estimate the number of functional channels expressed in CHO cells, we used nonstationary fluctuation analysis of whole-cell KCNQ4 currents using tail currents elicited at -100 mV. Figure 4 plots variance as a function of mean current for KCNQ4_v1 and KCNQ4_v4. The peak of the parabolic fit yields the number of functional channels (N), which is significantly higher for KCNQ4_v4 than KCNQ4_v1 (KCNQ4_v1 N=780 + 142; KCNQ4_v4 N=3004 + 719; n = 5; p < 0.01). Moreover, estimates from the unitary current amplitude (i) from the nonstationary fluctuation analysis suggest that the single channel currents may also differ between the two isoforms (KCNQ4_v1 i=0.6 + 0.3 pA; KCNQ4_v4 i=1.4 + 0.4 pA; n = 5; p < 0.05). Lack of the 54 aa at the C-terminal of the KCNQ4_v4 rendered the channel more accessible to functional membrane expression. We illustrate in figure 5 that membrane expression of KCNQ4_v4 is relatively more robust than that of KCNQ4_v1.
We sought to delineate the role of heteromultimeric interactions in the current magnitude and voltage-dependent properties of the KCNQ4 channels. Transfection of CHO cells with a combination of KCNQ4 splice variants produced current magnitudes and voltage dependences that were consistent with the formation of heteromeric channels. For example, the magnitude of the resulting current was not always in accord with independent addition of the homomeric current amplitude, and the voltagedependent activation of the current could not be predicted by simple addition of two independent channel currents ( Fig. 6 ). Several ion channel mutations have been identified that are capable of disabling channel activities in a DN manner when normal and defective subunits co-assemble to form multimeric complexes. If indeed the KCNQ4 channels form heteromultimers, then a DN mutant of one variant should cripple the functional channels. A 853 G→T mutation that produces a missense mutation of Gly 285 →Ser (G285S) in the pore region (GYG) of KCNQ4_v1 has been identified, and the mutation G285S suppresses channel activity by ~90% in vivo (2) . The same mutation was introduced into KCNQ4_v1 and KCNQ4_v4 by site-directed mutagenesis techniques. Figure 7 shows that co-expression of the mutant channels KCNQ4_v1DN and KCNQ4_v4DN with the wild-type (WT) channels suppressed the corresponding WT current's magnitude (Fig.  7A & D) . In addition, co-expression of the mutant channels disabled the activity of KCNQ4_v2 and v_3 as well (Fig. 7B & C) . The functional implications for the impairment of other subtypes of KCNQ channels by KCNQ4DN were broadened by co-expressing the mutant channels with KCNQ1-3 and KCNQ5. Co-expression of KCNQ4_v1 and KCNQ2-5 yielded current amplitudes that suggested that the channels may form heteromultimers (Fig. 8) . Co-expression of the mutant channel had no effect on the functional expression of KCNQ1 (Fig. 9D) . Moreover, the mutant channel suppressed the activity of KCNQ2-3 and KCNQ5 (Figs. 8 and 9A-C&E Supplementary Fig 1) , revealing the possible disease mechanism of mutations of KCNQ4 in the inner ear.
Finally, we estimated the number of α-subunits that assemble to constitute functional KCNQ4 channels using the whole-cell current data in the presence of increasing amounts of the DN channels, as described earlier by MacKinnon, 1991 (26) . Figure 9E shows that co-expression of KCNQ2-5 and the DN channels are likely to form a tetramer, an observation that was expected yet nonetheless reassuring, given the multiple distinct subtypes of KCNQ4 channels from the inner ear.
CaM interacts with the KCNQ channels at the C-termini and has been shown to produce both marked reduction in current in some cases (13) as well as unremarkable effects in other cases (11) . Because of differences in the putative CaMBDs in the different splice variants of KCNQ4 (Fig. 1) , we assessed the functional consequences of this interaction. It has been reported that CaM may be limiting in heterologous expression systems and that CHO cells may express endogenous CaM (11) . Thus, we co-expressed wild-type CaM (WT) and CaMDN: CaM with alanine substitutions for each of four aspartates in all four Ca 2+ -binding EF hands (D20A, D56A, D93A and D129A) (13) . Consistent with our expectation, co-expression of CaMWT with the channels did not produce significant changes in the current density. However, co-expression with CaMDN resulted in increased current magnitude. CaM produced differential alterations in channel current for each of the KCNQ4 splice variants. Whereas the CaMDN significantly increased the magnitude of KCNQ4_v1, 3, & 4 currents, CaMDN had no effect on the amplitude of KCNQ4_v2-mediated current. CaMDN did not alter the voltage-dependent properties of any of the currents (Fig. 10) .
DISCUSSION
In this report we have demonstrated that the functional phenotypes, voltagedependent activation, and levels of expression as well as CaM moderation of KCNQ4 channels is dictated by the outcome of alternative splicing at exons 9, 10 and 11. Specifically, the different utilization of exons 9, 10 and 11 enables the C-terminal to be altered in multiple functional contexts: (1) Positive activation-voltage and lowlevels of expression for KCNQ4_v1 (Δexon9, Δexon11), (2) "intermediate" negative activation-voltage and moderate expression for KCNQ4_v2 (Δexon9, Δexon10) and Modulation of KCNQ4 by second messengers may produce another element of I K,n diversity. CaM binds to the C-termini of KCNQ channels, possibly as a constitutive auxiliary subunit (11, 12) , and CaM mediates a Ca 2+ -dependent inhibition of the neuronal M-type K + current (13) . Conserved among the C-termini of all five KCNQ family members are two identifiable "IQ" motifs (8) (36)). Moreover, it has been established recently that the MPR of the C-terminal of KCNQ2-3 are important for targeting KCNQ channels to axonal surfaces (14) . The importance of specific membrane targeting/surface distribution of KCNQ channels is underscored by the findings that several BFNC mutations at the MPR of KCNQ2-3 disrupts and impairs targeting of the channels to axonal surfaces (14) . Indeed, the splicing variation in the HC-specific KCNQ4 coincides with the MPR of KCNQ channels. Thus the differential membrane expression of KCNQ4_v1 and 4 may have similarly important physiological implications.
Previous studies have documented that the voltage-dependent activation properties of the I K,n in HCs was shifted leftward by ~50 mV compared to expressed KCNQ channel currents (4, 10) . The Ctermini of KCNQ channels are also substrates for PKA phosphorylation, and application of 8-bromo-cAMP or the catalytic PKA subunit shifts the voltagedependent activation of KCNQ4 currents by ~-20 mV (23,37). Although application of cAMP produces ~15 mV leftward shift in the voltage-dependent activation of KCNQ4_v4 (data not shown), changes in activation of PKA alone may not suffice to confer the native HC channel properties. Recapitulation of the native cell current phenotype may require identification of other interacting proteins. Hints of the possible association of KCNQ4 channels with other proteins can be seen in the clustered localization of the channel at the basal pole of HCs, where postsynaptic density (PSD) protein labeling is found (38). We have identified an internal PDZ (PSD-95) binding motif (KTXXXI) near the KCNQ4 C-terminus. PSD-95 was shown to induce clustered expression of K + channels on the cell surface (39). It is evident that the important functional sequences and properties identified in this study will be useful in future investigations on the mechanism of PHFHL mediated by mutations in KCNQ4 channels. Expression of inner ear-specific KCNQ4_v1 in CHO cells A Examples of outward KCNQ4_v1 current traces recorded from a holding potential of -70 mV to step potentials ranging from -100 to 60 mV using voltage increment of 10 mV step. B Current density (in pA/pF)-voltage relations of summary data from 18 cells are shown. C Current traces generated with a two-pulse protocol to generate tail currents for the instantaneous current-voltage relation. The cell was held at -70 mV (not shown) and stepped to 30 mV and then stepped between -120 to 30 mV, at ΔV = 10 mV. The E rev was -85 + 3 mV (n = 9). To ensure clarity, not all the current traces were shown. D The activation curves were fitted with a Boltzmann function and the V 1/2 was -0.2 + 3.2 mV and the slope factor, k, was 15.2 + 1.8 mV. The conductance (g) of the channel was determined experimentally (E rev ~ -85 mV). The data represent mean + std from 18 cells. E The time courses of the effect of linopirdine (lino) and bepridil, known blockers of the KCNQ4 channel-current, on KCNQ4_v1 channel. F The dose-response curve of the effects of linopirdine. The estimated IC 50 was 10.8 + 0.1 μM, n = 5; ~11 μM).
Figure 3
Activation properties of KCNQ4_v1-4 channel variants A Exemplary outward KCNQ4 current traces recorded from a holding potential of -70 mV to 60 mV using voltage increment of 10 mV in depolarizing and hyperpolarizing step voltages shown. B Current density (in pA/pF)-voltage relations of summary data from 18 cells are shown for the four splice variants of KCNQ4. Invariably, the magnitude of KCNQ4_v4 current density was at least 10-fold larger than the KCNQ4_v1 current. For example, the descriptive statistics of the current densities elicited from a holding potential of -70 mV to 60 mV were 9.9 + 2.9; 25.3 + 2.6; 31.8 + 2.1; and 111.4 + 9.4 for KCNQ4_v1, 4v_2, 4v_3, and 4v_4, respectively (n = 18; p < 0.05). C The steady-state activation curves were generated from tail currents of the four variants. Activation properties of heteromeric KCNQ4 channels Whole-cell outward current recorded upon co-expressing KCNQ4_v4 and KCNQ4_v1-3 at a ratio of 1:1. Representative current traces for a family of K + currents obtained from a holding potential of -70 mV and stepped up to 60 mV using ΔV = 10 mV are shown on the right panel. The tail currents were elicited at -40 mV. A Plots of current density-voltage relation of currents derived from KCNQ4_v1 (v_1, ■) and KCNQ4_v4 (v_4, •) alone, and a combination of KCNQ4_v1 and KCNQ4_v4 (1:1, ○). Whereas the current density (pA/pF) at a step potential of 60 mV for KCNQ4_v1 was 9.9 + 2.9, the value for KCNQ4_v4 was 113.1 + 9.1, as compared to the combined KCNQ4_v1:KCNQ4_v4 current, which was 48.4 + 13.3 (n = 11; p < 0.05). B Plot of group data of current density-voltage curves obtained from ten CHO cells were transfected with KCNQ4_v2 alone, and in combination with KCNQ4_v4 (1:1). The voltages at which there are significant differences are indicated with *. At a step potential of 60 mV the current densities were: 113.1 + 9.1; 25.1 + 3.0; and 101 + 16.1 (n = 11; p = 0.6) for KCNQ4_v4, KCNQ4_v2 and combined KCNQ4_v2:KCNQ4_v4, respectively. C Similar experiments using KCNQ4_v3 alone and combined KCNQ4_v3:KCNQ4_v4 showing that co-expression of both channels resulted in current densities that were statistically different from the individuals channel alone at the tested voltages. D A summary histograph of the V 1/2 of the steady-state activation curves of the four splice variants and the combined channel currents showing statistical differences among the currents that ensue. In contrast the slope factor (k) of the resulting Boltzmann function curves were not statistically different. A 853 G→T mutation that produces a missense mutation of Gly285Ser in the pore region (GYG) of KCNQ4_v1 was introduced into KCNQ4_v1 and KCNQ4_v4 and co-expressed with wild type KCNQ4_v1-4 channels at a ratio of 1:1. Shown in A-D are the current-densities and voltage relation illustrating the effects of the crippling effects the dominant negative channels on the WT current. Representative current traces are shown in the insets besides the plots. The single point mutation in one isoform of KCNQ4, KCNQ4_v1DN or KCNQ4_v4DN significantly reduced currents of all four KCNQ4_v1-4 currents, suggesting that the channels form heteromultimers.
Figure 8
KCNQ4_v1 channels were co-expressed with other KCNQ channels in CHO cells at a ratio of 1:1, and the whole-cell outward currents were recorded. Representative current traces of homomeric and heteromeric KCNQ4 channels as indicated. Group data of current densityvoltage curves (mean + SD) for co-expression of KCNQ4_v1 with KCNQ2 or KCNQ3 were showed in A and B Averaged channel currents obtained in CHO cells transfected with KCNQ4_v1and KCNQ5, or co-transfected, with KCNQ4_v1 and KCNQ5 by a depolarization step from a holding potential (HP) of -70 mV to +20 mV (mean + SD), are shown in C.
Figure 9
Effects of KCNQ4_v1DN on other KCNQ channels KCNQ4_v1DN has specific suppressive effect on KCNQ2-5 but not KCNQ1. A Steady-state current density voltage relationship of currents from CHO cells that were co-transfected with KCNQ5 and KCNQ4_v1DN at different ratios as indicated (KCNQ5:KCNQ4_v1DN: 4:0 (•), 3:1 (○) 2:2 (■) 4:0 (□). Whole cell KCNQ5 currents were suppressed by KCNQ4_v1DN over the entire voltage range studied but the reversal potential was not changed suggesting that the permeation properties of the channel remained unaltered. B The effect of KCNQ4_v1DN on KCNQ5 currents did not alter the gating properties. Steady-state activation curves of KCNQ5 alone (•) and after suppression by KCNQ4_v1DN (○: ratio 3:1). Tail currents were measured immediately after pulsing to -120 mV, normalized to the largest tail recorded and plotted against the preceding pre-pulse voltages. Neither the midpoint (V 1/2 ) nor the slope factors (k) were statistically different among the two groups. The V 1/2 and k for KCNQ5 alone and KCNQ5/KCNQ4_v1DN were -36.3 + 1.2 mV, 12.1 + 1.1 mV, and 36.9 + 0.8 mV, 11.6 + 2.6 mV, (n = 7; p = 0.2 and 0.4), respectively. C Summary of the activation and deactivation time constants (τ) of currents induced by transfecting KCNQ5 alone (•) and KCNQ5/KCNQ4_v1DN (3:1; ○) showing that the distribution of τ was bell-shaped with midpoints similar to those derived from the corresponding steady-state activation curves. Thus, gating kinetics of expressed KCNQ5 currents were also not altered by KCNQ4_v1DN co-transfection. D Unlike KCNQ2-5 channels, co-tranfection of KCNQ1 (control; ■) with KCNQ4_v1DN (□) or KCNQ4_v4DN; (•) did not change current magnitude over the entire voltage range tested (n = 9). E Current suppression of KCNQ2-5 (wild-type, WT) by KCNQ4_v1DN versus WT:KCNQ4_v4DN ratio of DNA transfected. Suppression of KCNQ2-5 currents increased with decreasing WT:KCNQ4_DN ratio. Dashed lines denote the predicted suppression-ratio expected if the channels form dimers, trimers, tetramers and pentamers. The experimental data is in accord with the predicted relationship of tetramers, demonstrating that KCNQ2-5 co-assemble equally well with each other to form tetrameric functional channels. In addition the slope factors of the activation curves were unaltered (not listed). KCNQ4 channels were modulated differentially by Ca 2+ /calmodulin, which is consistent with the fact that alternative splicing introduces the variations in CaMBD in different KCNQ4 isoforms. Supplementary Fig. 1 . RT-PCR detection of KCNQ2, KCNQ3, KCNQ4 and KCNQ5 in the mouse inner ear. Using channel-specific primers and mRNA from mouse organ of Corti, a single band with the expected size of ~600 bp was obtained for KCNQ2, KCNQ3 and KCNQ5 respectively, at various densities (top bands). The PCR products were sequenced and they are responding to mouse KCNQ2 (446-1050, 605 bp), KCNQ3 (286-887, 602 bp) and KCNQ5 (1236-1835, 600 bp). Actin was amplified as internal control (low bands) indicating that the amount of RNA used in each PCR is comparable. M: DNA molecular weight marker; NTC: no template control Supplementary Fig. 1 .
RT-PCR detection of KCNQ2, KCNQ3, KCNQ4 and KCNQ5 in the mouse inner ear. Using channel-specific primers and mRNA from mouse organ of Corti, a single band with the expected size of ~600 bp was obtained for KCNQ2, KCNQ3 and KCNQ5 respectively, at various densities (top bands). The PCR products were sequenced and they are responding to mouse KCNQ2 (446-1050, 605 bp), KCNQ3 (286-887, 602 bp) and KCNQ5 (1236-1835, 600 bp). Actin was amplified as internal control (low bands) indicating that the amount of RNA used in each PCR is comparable. M: DNA molecular weight marker; NTC: no template control
